Cell Therapy News Volume 25.13 | Apr 15 2024

    0
    8








    2024-04-15 | CTN 25.13


    Cell Therapy News by STEMCELL Technologies
    Vol. 25.13 – 15 April, 2024
    TOP STORY

    FOXO1 Enhances CAR T Cell Stemness, Metabolic Fitness, and Efficacy

    Researchers showed that overexpression of FOXO1 promoted a stem-like phenotype in CAR T cells derived from either healthy human donors or patients, which correlated with improved mitochondrial fitness, persistence and therapeutic efficacy in vivo.
    [Nature]

    Full Article
    PUBLICATIONSRanked by the impact factor of the journal

    CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma

    Investigators reported that CTX130 showed favorable preclinical proliferation and cytotoxicity profiles and completely regressed renal cell carcinoma xenograft tumors.
    [Cancer Discovery]

    Abstract

    Donor Regulatory T Cells Rapidly Adapt to Recipient Tissues to Control Murine Acute Graft-Versus-Host Disease

    The authors used a major histocompatibility complex-mismatched mouse model to follow the fate of in vitro expanded donor regulatory T cells upon migration to target organs
    [Nature Communications]

    Full Article

    Self-Regulating CAR-T Cells Modulate Cytokine Release Syndrome in Adoptive T Cell Therapy

    With a humanized NSG-SGM3 mouse model, scientists showed reduced CRS-related toxicity in mice treated with CAR-T cells secreting tocilizumab-derived single-chain variable fragment, yielding a safety profile superior to that of single-dose systemic tocilizumab administration.
    [Journal Of Experimental Medicine]

    Abstract

    Identification and Removal of Unexpected Proliferative Off-Target Cells Emerging after iPSC-Derived Pancreatic Islet Cell Implantation

    Investigators showed that the implantation of seven-stage induced PSC-derived pancreatic islet cells led to the emergence of unexpected off-target cells with proliferative capacity via in vivo maturation.
    [Proceedings Of The National Academy Of Sciences Of The United States Of America]

    Full Article

    PD-1 Downregulation Enhances CAR-T Cell Antitumor Efficiency by Preserving a Cell Memory Phenotype and Reducing Exhaustion

    Researchers incorporated a short hairpin RNA cassette targeting PD-1 into a B cell maturation antigen-CAR with an OX-40 costimulatory domain.
    [Journal For Immunotherapy Of Cancer]

    Abstract

    Phase I Study Combining Elotuzumab with Autologous Stem Cell Transplant and Lenalidomide for Multiple Myeloma

    The authors conducted a Phase I clinical trial to investigate the application of autologous lymphocyte infusion and anti-SLAMF7 monoclonal antibody, elotuzumab, after autologous stem cell transplantation in patients with newly diagnosed multiple myeloma previously treated with induction therapy.
    [Journal For Immunotherapy Of Cancer]

    Abstract

    CD4+ CAR-T Cell Exhaustion Associated with Early Relapse of Multiple Myeloma after BCMA CAR-T Cell Therapy

    While there were no pre-existing T cell features associated with clinical outcomes, scientists found that patients with a durable response to CAR-T cell treatment had greater persistence of their CAR-T cells compared to patients with transient clinical responses.
    [Blood Advances]

    Abstract

    Expression and Processing of Mature Human Frataxin after Gene Therapy in Mice

    Researchers assessed mature exogenous rataxin in humans (hFXN expression levels in the heart and liver of C57Bl/6 mice seven-ten months after intravenous administration of a recombinant adeno-associated virus encoding hFXN and examined the potential for hFXN truncation in mice.
    [Scientific Reports]

    Full Article

    Banner Ad Cross Reference Banner Ad Cross Reference 100% 10 E17 Visit the Hematopoiesis Resource Center for videos, tips, and protocols to help with your research questions. Screen reader support enabled. Visit the Hematopoiesis Resource Center for videos, tips, and protocols to help with your research questions. Turn on screen reader support
    REVIEWS

    Direct In Vivo CAR T Cell Engineering

    The authors outline the ex vivo manufacturing process as a motivating framework for direct in vivo strategies and discuss emerging data from preclinical models to highlight the potency of the in vivo approach
    [Trends In Pharmacological Sciences]

    Full Article

    In Vivo Manufacture and Manipulation of CAR-T Cells for Better Druggability

    The utilization of genetically modified vectors enables in vivo production of CAR-T cells, thereby abbreviating or skipping the lengthy in vitro expansion process.
    [Cancer And Metastasis Reviews]

    Abstract
    INDUSTRY AND POLICY NEWS

    UFC Announces Global Marketing Partnership with Stem Cell Therapy Leader Cellular Performance Institute

    UFC, the world’s premier mixed martial arts organization, and Cellular Performance Institute (CPI), the world’s foremost advanced stem cell and regenerative medicine company, announced a new global marketing partnership that will showcase CPI branding within some of UFC’s biggest events.
    [UFC]

    Press Release

    This Startup Wants To Be OpenAI Of Stem Cell Therapy, Targets $250B Market

    Five scientists walked into a lab late last year and decided to establish a startup combining their wide-ranging expertise, practical experience and breakthrough innovations. The goal of their startup, Somite.ai, is to improve the lives of millions of people by leveraging AI to produce human tissue for cell therapies.
    [Forbes]

    Press Release
    FEATURED EVENT

    Cancer and Aging – The Inflammaging Connection

    May 20, 2024
    New York, New York, United States & Online

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Scholar – Synthetic Extracellular Matrix

    University of Oregon – Eugene, Oregon, United States

    Cell Manufacturing Specialist – Cell Therapy

    University of Wisconsin-Madison – Madison, Wisconsin, United States

    PhD Scholarship – Regulatory T Cell Therapy for Inflammatory Bowel Disease

    Monash University – Melbourne, Victoria, Australia

    Associate Director – Stravitz-Sanyal Institute for Liver Disease

    Virginia Commonwealth University – Richmond, Virginia, United States

    Research Associate – Bioprinting, Biomaterials, and Tissue Engineering

    New York University Abu Dhabi – Abu Dhabi, United Arab Emirates

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2